Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation*

Stat5 and Stat3, two members of the Stat (signal transducer and activator of transcription) family, are known to play critical roles in mammopoiesis/lactogenesis and involution, respectively, in the mammary gland. Phosphotyrosine phosphatase Shp2 has been shown to dephosphorylate and thus inactivate both Stat5 and Stat3 in vitro. Paradoxically, cell culture studies also suggest a positive role of Shp2 in promoting prolactin-stimulated Stat5 activation. We have shown here that selective deletion of Shp2 in mouse mammary glands suppresses Stat5 activity during pregnancy and lactation, resulting in significant impairment of lobulo-alveolar outgrowth and lactation. In contrast, Stat3 activity was slightly up-regulated shortly before/at involution, leading to normal epithelial cell apoptosis/involution in Shp2-deficient mammary gland. Thus, Shp2 acts to promote Stat5 activation by the JAK2·prolactin receptor complex, while negatively modulating Stat3 activity before the onset of involution. This is the first demonstration that Shp2 manipulates Stat5 and Stat3 activities reciprocally in mammary epithelial cells, providing novel insight into the complex mechanisms for regulation of various Stat family members by a cytoplasmic tyrosine phosphatase.

[1]  G. Feng,et al.  Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  N. Huntington,et al.  CD45: direct and indirect government of immune regulation. , 2004, Immunology letters.

[3]  S. Ali,et al.  SHP-2 Regulates SOCS-1-mediated Janus Kinase-2 Ubiquitination/Degradation Downstream of the Prolactin Receptor* , 2003, Journal of Biological Chemistry.

[4]  G. Feng,et al.  A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis. , 2003, Blood.

[5]  D. Radisky,et al.  Delivering the message: epimorphin and mammary epithelial morphogenesis. , 2003, Trends in cell biology.

[6]  C. Watson,et al.  A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland , 2003, Development.

[7]  B. Neel,et al.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. , 2003, Trends in biochemical sciences.

[8]  G. Feng,et al.  Identification of Shp-2 as a Stat5A Phosphatase* , 2003, The Journal of Biological Chemistry.

[9]  Satoru Shiono,et al.  Control mechanism of JAK/STAT signal transduction pathway , 2003, FEBS letters.

[10]  G. Feng,et al.  SHP-2 Is a Dual-specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in Nuclei* , 2002, The Journal of Biological Chemistry.

[11]  B. Groner,et al.  Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. , 2002, Molecular cancer research : MCR.

[12]  L. Hennighausen,et al.  Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. , 2002, Development.

[13]  D. Levy,et al.  Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. , 2002, Endocrinology.

[14]  Jean-Jacques Lebrun,et al.  Prolactin Induces SHP-2 Association with Stat5, Nuclear Translocation, and Binding to the β-Casein Gene Promoter in Mammary Cells* , 2002, The Journal of Biological Chemistry.

[15]  D. Hilton,et al.  Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1 , 2002, Molecular and Cellular Biology.

[16]  L. Hennighausen,et al.  Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice , 2001, Transgenic Research.

[17]  L. Hennighausen,et al.  Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium , 2001, The Journal of cell biology.

[18]  L. Hennighausen,et al.  Signaling pathways in mammary gland development. , 2001, Developmental cell.

[19]  J. G. Zhang,et al.  SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. , 2001, Genes & development.

[20]  J. Ihle The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.

[21]  B. Groner,et al.  Linear and cooperative signaling: roles for Stat proteins in the regulation of cell survival and apoptosis in the mammary epithelium , 2000, Breast Cancer Research.

[22]  S. Burakoff,et al.  Cytosolic Tyrosine Dephosphorylation of STAT5 , 2000, The Journal of Biological Chemistry.

[23]  S. Akira,et al.  Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. , 1999, Genes & development.

[24]  G. Feng,et al.  Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.

[25]  G. Feng,et al.  Shp-2 has a positive regulatory role in ES cell differentiation and proliferation , 1998, Oncogene.

[26]  L. Hennighausen,et al.  Think globally, act locally: the making of a mouse mammary gland. , 1998, Genes & development.

[27]  L. Hennighausen,et al.  Prolactin Signaling in Mammary Gland Development* , 1997, The Journal of Biological Chemistry.

[28]  C. Watson,et al.  Edinburgh Research Explorer Differential activation of STATs 3 and 5 during mammary gland development , 2022 .

[29]  A. Ullrich,et al.  PTP1D is a positive regulator of the prolactin signal leading to beta‐casein promoter activation. , 1996, The EMBO journal.

[30]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[31]  G. Feng,et al.  The Shp-2 tyrosine phosphatase , 2004 .